Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults

Abstract Background We evaluated an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine for immunogenicity and safety in adults aged 18–59 years. Methods In this randomized, double-blinded, controlled trial, healthy adults received a medium dose (MD) or a high dose (HD)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2021-12, Vol.73 (11), p.e3949-e3955
Hauptverfasser:	Che, Yanchun, Liu, Xiaoqiang, Pu, Yi, Zhou, Meijian, Zhao, Zhimei, Jiang, Ruiju, Yin, Zhifang, Xu, Mingjue, Yin, Qiongzhou, Wang, Jianfeng, Pu, Jing, Zhao, Heng, Zhang, Ying, Wang, Lichun, Jiang, Ya, Lei, Jin, Zheng, Yan, Liao, Yun, Long, Runxiang, Yu, Li, Cui, Pingfang, Yang, Huijuan, Zhang, Yuehui, Li, Jingyu, Chen, Weiwu, He, Zhanlong, Ma, Kaili, Hong, Chao, Li, Dandan, Jiang, Guorun, Liu, Donglan, Xu, Xingli, Fan, Shengtao, Cheng, Chen, Zhao, Hongling, Yang, Jianbo, Li, Yan, Zou, Yanxiang, Zhu, Youshuai, Zhou, Yaling, Guo, Yingqiu, Yang, Ting, Chen, Hongbo, Xie, Zhongping, Li, Changgui, Li, Qihan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!